Skip to main content

Lukatch Heath's Form 4 filing

Vaxcyte, Inc. (PCVX) · filed Oct 26, 2022

Accession no.
0001209191-22-054664
Filed
Oct 26, 2022
Trade date
Oct 24-26, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $258.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lukatch HeathCIK 0001596385Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2022Common StockMOption exerciseAcquired+3,015$16.00+$48,2406,140Direct
Oct 24, 2022Common StockSSaleDisposed−3,015$35.11−$105,856.653,125Direct
Oct 26, 2022Common StockMOption exerciseAcquired+4,000$16.00+$64,0007,125Direct
Oct 26, 2022Common StockSSaleDisposed−4,000$38.25−$153,0003,125Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 24, 2022Common StockDReturned to the companyDisposed−3,015$0.00$036,985Direct
Oct 26, 2022Common StockDReturned to the companyDisposed−4,000$0.00$032,985Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)